Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | EREG |
| Upstream (Parents) |
|---|
| (<<) ADORA2B → EREG |
| (<<) ASNS → EREG |
| (<<) ATIC → EREG |
| (<<) BZW2 → EREG |
| (<<) CFL1 → EREG |
| (<<) E2F1 → EREG |
| (<<) EPHB2 → EREG |
| (<<) GDF15 → EREG |
| (<<) HGS → EREG |
| (<<) MAPK13 → EREG |
| (<<) MYC → EREG |
| (<<) PRKAB1 → EREG |
| (<<) SLMO2 → EREG |
| (<<) UAP1 → EREG |
| (<<) UBE2C → EREG |
| (<<) VAV3 → EREG |
| (<<) YWHAB → EREG |
| Downstream (Children) |
|---|
| EREG → AREG (>>) |
| EREG → CBFA2T3 (>>) |
| EREG → CKB (>>) |
| EREG → DHRS9 (>>) |
| EREG → GNG4 (>>) |
| EREG → GPRIN2 (>>) |
| EREG → MAP3K5 (>>) |
| EREG → PLA2G4A (>>) |
| EREG → SEMA3A (>>) |
